About the Journal


The Journal of Pharmacology, Toxicology, and Drug Innovation (JPTD) is a peer‑reviewed scholarly journal published by FRIE. JPTD is scheduled to launch in 2026, offering a dedicated international forum for high-quality research in pharmacology, toxicology, drug discovery, and therapeutic innovation. The journal invites original research articles, review papers, short communications, case studies, and technical reports on topics such as drug design, pharmacodynamics, pharmacokinetics, toxicology assessments, medicinal chemistry, pharmacogenomics, and novel therapeutic strategies. JPTD encourages interdisciplinary submissions combining pharmaceutical science, biomedical research, toxicology, clinical pharmacology, and biotechnology, including preclinical and translational studies. All submitted manuscripts undergo a rigorous peer‑review process to ensure scientific validity, methodological rigor, clarity, and ethical compliance.


The journal welcomes contributions from academics, researchers, clinicians, industry scientists, and practitioners worldwide, aiming to reflect global diversity in pharmacological research and therapeutic innovation. JPTD seeks to advance knowledge in drug discovery, safety evaluation, and therapeutic development — promoting innovations that address unmet medical needs and public health challenges. The journal emphasizes transparency, reproducibility, and ethical standards in reporting pharmacological and toxicological research. Through its publications, JPTD aims to foster collaboration among scientists, encourage evidence‑based drug development, and disseminate cutting‑edge findings to accelerate progress in pharmacology and therapeutics globally.